1 withdrawn. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
Follow Stage 2-High dose VM202RY: new trials by email Literature Review of Stage 2-High dose VM202RY trials Research Report on Stage 2-High dose VM202RY
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study of Gene Therapy for Acute Myocardial Infarction in Korea Stage 1-Low dose VM202RY, Stage 1-Middle dose VM202RY, Stage 1-High dose VM202RY - Ischemic Heart Disease, Acute Myocardial Infarction | Phase 2 | Withdrawn | Helixmith Co., Ltd. | 2018-01-25 | 2025-09-25 |
South Korea (1)